mRNA治療薬の世界市場レポート 2025年

mRNA治療薬の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR（複合年間成長率）3.9％で422億3,000万米ドルに成長します。予測期間の成長は、感染症の増加、病院や診療所を訪れる患者数の増加、mRNA治療薬の用途拡大、個別化医療や精密医療への需要の高まり、有利な規制環境、承認経路の加速などに起因すると考えられます。予測期間の主な動向としては、mRNA送達技術の進歩、mRNAワクチンの急速な開発と適応、自己増幅mRNA（saRNA）プラットフォームの出現、mRNA製造の拡張性と柔軟性、新規mRNA修飾の開発などが挙げられます。

mRNA治療薬市場は、長期にわたる伝染性疾患の有病率の増加により、成長する見込みです。これらの病気は、長期間持続し、個人間で感染する可能性があり、結核、HIV/AIDS、肝炎などの疾患が含まれます。感染症増加の要因としては、世界の旅行や不十分なヘルスケア・インフラが挙げられ、これらは疾病の蔓延を促進し、効果的な管理を妨げています。mRNA治療薬は、免疫反応を高めるタンパク質を体内で速やかに産生することで、ワクチンや治療法の開発を加速させ、このような病気と闘う上で極めて重要です。例えば、2022年にイングランドでHIVと診断され治療を受けている人の数は9万4,397人に上り、2021年から3％増加しました。

mRNA治療薬市場の主要企業は、進化するウイルス変異体に対する免疫を強化するために、mRNAベースのブースターワクチンなどの先駆的ソリューションに注力しています。これらのワクチンは、メッセンジャーRNA（mRNA）技術を利用し、特に初回ワクチン接種後に特定の病原体に対する免疫を拡大・強化します。例えば、Gennova Biopharmaceuticals社は、2023年6月にインド初のmRNAベースのオミクロン特異的ブースターワクチンGEMCOVAC-OMを発売しました。SARS-CoV-2のオミクロン変異体と闘うように設計されたGEMCOVAC-OMは耐熱性があり、注射針なしで投与できるため、インドのラストワンマイル地域での展開が容易です。臨床試験では、他のワクチンに比べて免疫応答が有意に高まったことが示されており、亜種特異的アプローチの有効性が強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界mRNA治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のmRNA治療薬市場：成長率分析
• 世界のmRNA治療薬市場の実績：規模と成長, 2019-2024
• 世界のmRNA治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界mRNA治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のmRNA治療薬市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• 薬物
• 世界のmRNA治療薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 腫瘍学
• 希少遺伝性疾患
• 呼吸器疾患
• その他の用途
• 世界のmRNA治療薬市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 調査機関
• その他の用途
• 世界のmRNA治療薬市場、ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症ワクチン
• がんワクチン
• その他の治療ワクチン
• 世界のmRNA治療薬市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍薬
• 心血管薬
• 自己免疫疾患治療薬
• その他のmRNAベースの薬剤

第7章 地域別・国別分析

• 世界のmRNA治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のmRNA治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• mRNA治療薬市場：競合情勢
• mRNA治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Hoffmann-La Roche AG
• Moderna Therapeutics Inc.
• BioNTech SE
• Vertex Pharmaceuticals Incorporated
• Catalent Inc.
• Alnylam Pharmaceuticals Inc.
• Sarepta Therapeutics Inc.
• Arcturus Therapeutics Holdings Inc.
• CureVac N.V.
• Ethris GMBH
• eTheRNA immunotherapies NV
• In-Cell-Art S.A.S.
• Nutcracker Therapeutics Inc.
• SCM LifeScience Co. Ltd.
• Suzhou Abogen Biosciences Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• mRNA治療薬市場2029：新たな機会を提供する国
• mRNA治療薬市場2029：新たな機会を提供するセグメント
• mRNA治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Messenger RNA (mRNA) therapeutics involve utilizing mRNA molecules to prompt cells to produce therapeutic proteins within the body, aimed at preventing, treating, or curing diseases by facilitating the production of specific proteins necessary for therapeutic benefits.

The primary products in mRNA therapeutics include vaccines and drugs. mRNA vaccines instruct cells via mRNA to generate proteins that stimulate an immune response against targeted diseases. These vaccines find applications across various fields such as infectious diseases, oncology, rare genetic diseases, respiratory illnesses, among others. End users include hospitals, clinics, research organizations, and other healthcare providers.

The mRNA therapeutics market research report is one of a series of new reports from The Business Research Company that provides mRNA therapeutics market statistics, including mRNA therapeutics industry global market size, regional shares, competitors with a mRNA therapeutics market share, detailed mRNA therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the mRNA therapeutics industry. This mRNA therapeutics market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mRNA therapeutics market size has grown steadily in recent years. It will grow from $34.76 billion in 2024 to $36.25 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to increasing financial support for the creation of efficient pharmaceuticals and vaccines, the expansion of federal programs dedicated to advancing RNA-based medicines heightened awareness regarding rare genetic diseases, and a rise in the number of clinical trials.

The mRNA therapeutics market size is expected to see steady growth in the next few years. It will grow to $42.23 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to the growing number of infectious diseases, the increasing number of patients visiting hospitals and clinics, expanding applications of mRNA therapeutics, growing demand for personalized and precision medicine, favorable regulatory environments, and accelerated approval pathways. Major trends in the forecast period include advancements in mRNA delivery technologies, rapid development and adaptation of mRNA vaccines, the emergence of self-amplifying mRNA (saRNA) platforms, the scalability and flexibility of mRNA manufacturing, and the development of novel mRNA modifications.

The mRNA therapeutics market is poised for growth due to the increasing prevalence of long-lasting and communicable diseases. These diseases, which endure for extended periods and can be transmitted between individuals, include conditions such as tuberculosis, HIV/AIDS, and hepatitis. Factors contributing to their rise include global travel and inadequate healthcare infrastructure, which facilitate disease spread and hinder effective management. mRNA therapeutics are pivotal in combating such diseases by swiftly enabling the body to produce proteins that enhance immune responses, thereby accelerating the development of vaccines and treatments. For example, in 2022, the number of people in England living with diagnosed HIV and receiving care rose to 94,397, a 3% increase from 2021, highlighting the need for effective therapeutic advancements.

Leading companies in the mRNA therapeutics market are concentrating on pioneering solutions, such as mRNA-based booster vaccines, to bolster immunity against evolving viral variants. These vaccines utilize messenger RNA (mRNA) technology to extend and enhance immunity against specific pathogens, particularly following initial vaccination series. For instance, Gennova Biopharmaceuticals Ltd. launched India's first indigenous mRNA-based Omicron-specific booster vaccine, GEMCOVAC-OM, in June 2023. Designed to combat the Omicron variant of SARS-CoV-2, GEMCOVAC-OM is thermostable and can be administered without needle injection, facilitating easy deployment in India's last-mile regions. Clinical studies have shown significantly heightened immune responses compared to other vaccines, underscoring the efficacy of variant-specific approaches.

In May 2022, OPKO Health Inc., a US-based pharmaceutical company, acquired ModeX Therapeutics Inc. for around $300 million. The acquisition is designed to strengthen OPKO Health's oncology and infectious disease portfolio by incorporating ModeX's groundbreaking immune therapies. This move aims to expand OPKO's product pipeline and capitalize on synergies to accelerate development in crucial therapeutic areas. ModeX Therapeutics Inc. is a US-based biotechnology company specializing in mRNA therapeutics.

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mRNA therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mRNA therapeutics market consists of revenues earned by entities by providing services such as vaccine development, protein replacement therapies, gene editing, monoclonal antibody production, and cancer treatment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

mRNA Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mrna therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mrna therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mrna therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Vaccines; Drugs
• 2) By Application: Infectious Diseases; Oncology; Rare Genetic Diseases; Respiratory Diseases; Other Applications
• 3) By End Use: Hospitals And Clinics; Research Organizations; Other End Uses
• Subsegments:
• 1) By Vaccines: Infectious Disease Vaccines; Cancer Vaccines; Other Therapeutic Vaccines
• 2) By Drugs: Oncology Drugs; Cardiovascular Drugs; Autoimmune Disease Drugs; Other mRNA-Based Drugs
• Companies Mentioned: Pfizer Inc.; Novartis AG; Sanofi AG; AstraZeneca plc; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. mRNA Therapeutics Market Characteristics

3. mRNA Therapeutics Market Trends And Strategies

4. mRNA Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global mRNA Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global mRNA Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global mRNA Therapeutics Market Growth Rate Analysis
• 5.4. Global mRNA Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global mRNA Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global mRNA Therapeutics Total Addressable Market (TAM)

6. mRNA Therapeutics Market Segmentation

• 6.1. Global mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Drugs
• 6.2. Global mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Oncology
• Rare Genetic Diseases
• Respiratory Diseases
• Other Applications
• 6.3. Global mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Organizations
• Other End Uses
• 6.4. Global mRNA Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Vaccines
• Cancer Vaccines
• Other Therapeutic Vaccines
• 6.5. Global mRNA Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Drugs
• Cardiovascular Drugs
• Autoimmune Disease Drugs
• Other mRNA-Based Drugs

7. mRNA Therapeutics Market Regional And Country Analysis

• 7.1. Global mRNA Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global mRNA Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific mRNA Therapeutics Market

• 8.1. Asia-Pacific mRNA Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China mRNA Therapeutics Market

• 9.1. China mRNA Therapeutics Market Overview
• 9.2. China mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India mRNA Therapeutics Market

• 10.1. India mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan mRNA Therapeutics Market

• 11.1. Japan mRNA Therapeutics Market Overview
• 11.2. Japan mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia mRNA Therapeutics Market

• 12.1. Australia mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia mRNA Therapeutics Market

• 13.1. Indonesia mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea mRNA Therapeutics Market

• 14.1. South Korea mRNA Therapeutics Market Overview
• 14.2. South Korea mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe mRNA Therapeutics Market

• 15.1. Western Europe mRNA Therapeutics Market Overview
• 15.2. Western Europe mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK mRNA Therapeutics Market

• 16.1. UK mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany mRNA Therapeutics Market

• 17.1. Germany mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France mRNA Therapeutics Market

• 18.1. France mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy mRNA Therapeutics Market

• 19.1. Italy mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain mRNA Therapeutics Market

• 20.1. Spain mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe mRNA Therapeutics Market

• 21.1. Eastern Europe mRNA Therapeutics Market Overview
• 21.2. Eastern Europe mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia mRNA Therapeutics Market

• 22.1. Russia mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America mRNA Therapeutics Market

• 23.1. North America mRNA Therapeutics Market Overview
• 23.2. North America mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA mRNA Therapeutics Market

• 24.1. USA mRNA Therapeutics Market Overview
• 24.2. USA mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada mRNA Therapeutics Market

• 25.1. Canada mRNA Therapeutics Market Overview
• 25.2. Canada mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America mRNA Therapeutics Market

• 26.1. South America mRNA Therapeutics Market Overview
• 26.2. South America mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil mRNA Therapeutics Market

• 27.1. Brazil mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East mRNA Therapeutics Market

• 28.1. Middle East mRNA Therapeutics Market Overview
• 28.2. Middle East mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa mRNA Therapeutics Market

• 29.1. Africa mRNA Therapeutics Market Overview
• 29.2. Africa mRNA Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa mRNA Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa mRNA Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. mRNA Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. mRNA Therapeutics Market Competitive Landscape
• 30.2. mRNA Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. mRNA Therapeutics Market Other Major And Innovative Companies

• 31.1. Hoffmann-La Roche AG
• 31.2. Moderna Therapeutics Inc.
• 31.3. BioNTech SE
• 31.4. Vertex Pharmaceuticals Incorporated
• 31.5. Catalent Inc.
• 31.6. Alnylam Pharmaceuticals Inc.
• 31.7. Sarepta Therapeutics Inc.
• 31.8. Arcturus Therapeutics Holdings Inc.
• 31.9. CureVac N.V.
• 31.10. Ethris GMBH
• 31.11. eTheRNA immunotherapies NV
• 31.12. In-Cell-Art S.A.S.
• 31.13. Nutcracker Therapeutics Inc.
• 31.14. SCM LifeScience Co. Ltd.
• 31.15. Suzhou Abogen Biosciences Co. Ltd.

32. Global mRNA Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The mRNA Therapeutics Market

34. Recent Developments In The mRNA Therapeutics Market

35. mRNA Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 mRNA Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 mRNA Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 mRNA Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer